Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Bivaluridin Education Material for medically managed ACS patients

Bivaluridin Education Material for medically managed ACS patients: Treatment of adult patients with unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI) planned for urgent or early intervention. Bivalirudin should be administered with acetylsalicylic acid and clopidogrel.

For Healthcare Professionals

Bivaluridin Education Material for PCI and Primary PCI

After reconstitution 1ml contains 50mg bivalirudin. After dilution 1ml contains 5mg bivalirudin. Indications: Bivalirudin is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (PCI), including patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. Bivalirudin is also indicated for the treatment of adult patients with unstable angina/ non-ST segment elevation myocardial infarction (UA/NSTEMI) planned for urgent or early intervention. Bivalirudin should be administered with acetylsalicylic acid and clopidogrel.

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.